NewAmsterdam Pharma Company N.V.
Rachunek Zysków i Strat
index |
0 |
1 |
2 |
3 |
4 |
5 |
6 |
7 |
8 |
9 |
10 |
11 |
12 |
13 |
14 |
15 |
16 |
17 |
18 |
19 |
20 |
Rok finansowy |
2020 |
2020 |
2020 |
2020 |
2021 |
2021 |
2021 |
2021 |
2022 |
2022 |
2022 |
2022 |
2023 |
2023 |
2023 |
2023 |
2024 |
2024 |
2024 |
2024 |
2025 |
Kwartał |
Q1 |
Q2 |
Q3 |
Q4 |
Q1 |
Q2 |
Q3 |
Q4 |
Q1 |
Q2 |
Q3 |
Q4 |
Q1 |
Q2 |
Q3 |
Q4 |
Q1 |
Q2 |
Q3 |
Q4 |
Q1 |
Data |
2020-03-31 |
2020-06-30 |
2020-09-30 |
2020-12-31 |
2021-03-31 |
2021-06-30 |
2021-09-30 |
2021-12-31 |
2022-03-31 |
2022-06-30 |
2022-09-30 |
2022-12-31 |
2023-03-31 |
2023-06-30 |
2023-09-30 |
2023-12-31 |
2024-03-31 |
2024-06-30 |
2024-09-30 |
2024-12-31 |
2025-03-31 |
Przychód (mln) |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
47 |
47 |
6 |
1 |
8 |
2 |
2 |
2 |
1 |
2 |
29 |
13 |
3 |
Przychód Δ kw/kw |
0.0% |
0.0% |
0.0% |
0.0% |
0.0% |
0.0% |
0.0% |
0.0% |
inf% |
inf% |
inf% |
inf% |
-82.98% |
-96.63% |
-66.58% |
23.3% |
-83.68% |
35.2% |
1450.7% |
701.0% |
129.4% |
Marża brutto |
0.0% |
0.0% |
0.0% |
0.0% |
0.0% |
0.0% |
0.0% |
0.0% |
100.0% |
100.0% |
100.0% |
100.0% |
100.0% |
100.0% |
100.0% |
100.0% |
100.0% |
99.2% |
100.0% |
100.0% |
100.0% |
Koszty i Wydatki (mln) |
1 |
1 |
1 |
0 |
5 |
5 |
10 |
17 |
19 |
19 |
44 |
39 |
48 |
41 |
51 |
47 |
91 |
43 |
53 |
56 |
72 |
EBIT (mln) |
-1 |
-1 |
-1 |
-0 |
-5 |
-5 |
-10 |
-11 |
27 |
27 |
-29 |
-28 |
-37 |
-39 |
-48 |
-44 |
-51 |
-49 |
-24 |
-43 |
-69 |
EBIT Δ kw/kw |
0.0% |
0.0% |
0.0% |
0.0% |
266.7% |
266.7% |
632.4% |
10301.2% |
638.7% |
638.7% |
188.1% |
161.9% |
-237.05% |
-245.21% |
67.5% |
55.9% |
39.9% |
26.1% |
-49.21% |
-2.41% |
34.1% |
EBIT (%) |
0.0% |
0.0% |
0.0% |
0.0% |
0.0% |
0.0% |
0.0% |
0.0% |
57.3% |
57.3% |
-509.88% |
-2198.04% |
-461.85% |
-2474.20% |
-2555.05% |
-2777.93% |
-3960.17% |
-2306.93% |
-83.69% |
-338.47% |
-2314.47% |
Przychody fiansowe (mln) |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
1 |
4 |
3 |
3 |
3 |
5 |
4 |
4 |
7 |
Koszty finansowe (mln) |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
1 |
3 |
1 |
2 |
1 |
1 |
1 |
-3 |
0 |
Amortyzacja (mln) |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
EBITDA (mln) |
-1 |
-1 |
-1 |
-0 |
-5 |
-5 |
-10 |
-11 |
27 |
27 |
-29 |
22 |
-39 |
-39 |
-48 |
-44 |
-55 |
-49 |
-24 |
-112 |
-69 |
EBITDA(%) |
0.0% |
0.0% |
0.0% |
0.0% |
0.0% |
0.0% |
0.0% |
0.0% |
57.4% |
57.4% |
-509.74% |
-2197.88% |
-461.75% |
-2473.44% |
-2554.72% |
-2777.61% |
-3959.10% |
-2306.10% |
-81.89% |
-874.51% |
-2312.73% |
NOPLAT (mln) |
-1 |
-1 |
-1 |
0 |
-5 |
-5 |
-10 |
-18 |
27 |
27 |
-39 |
-38 |
-39 |
-35 |
-46 |
-43 |
-87 |
-36 |
-17 |
-92 |
-40 |
Podatek (mln) |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
-0 |
0 |
0 |
Zysk Netto (mln) |
-1 |
-1 |
-1 |
0 |
-5 |
-5 |
-10 |
-18 |
27 |
27 |
-39 |
-38 |
-39 |
-35 |
-46 |
-43 |
-87 |
-36 |
-17 |
-92 |
-40 |
Zysk netto Δ kw/kw |
0.0% |
0.0% |
0.0% |
0.0% |
229.9% |
229.9% |
565.1% |
-52306.27% |
674.9% |
674.9% |
306.2% |
113.6% |
-242.12% |
-228.74% |
18.7% |
12.6% |
124.3% |
3.8% |
-63.88% |
116.7% |
-54.51% |
Zysk netto (%) |
0.0% |
0.0% |
0.0% |
0.0% |
0.0% |
0.0% |
0.0% |
0.0% |
58.3% |
58.3% |
-691.13% |
-2921.58% |
-486.94% |
-2230.11% |
-2455.00% |
-2667.72% |
-6692.87% |
-1711.58% |
-57.18% |
-721.71% |
-1327.30% |
EPS |
-0.0167 |
-0.0167 |
-0.0167 |
0.0019 |
-0.43 |
-0.43 |
-0.82 |
-1.73 |
0.75 |
0.75 |
-23.19 |
-2.06 |
-0.47 |
-0.43 |
-0.56 |
-0.52 |
-0.98 |
-0.38 |
-0.18 |
-0.98 |
-0.34 |
EPS (rozwodnione) |
-0.0167 |
-0.0167 |
-0.0167 |
0.0019 |
-0.43 |
-0.43 |
-0.82 |
-1.73 |
0.68 |
0.67 |
-23.22 |
-2.06 |
-0.47 |
-0.43 |
-0.56 |
-0.52 |
-0.98 |
-0.38 |
-0.18 |
-0.98 |
-0.34 |
Ilośc akcji (mln) |
86 |
86 |
86 |
18 |
18 |
18 |
18 |
18 |
18 |
18 |
18 |
18 |
82 |
82 |
82 |
82 |
82 |
95 |
95 |
94 |
116 |
Ważona ilośc akcji (mln) |
86 |
86 |
86 |
18 |
18 |
18 |
18 |
18 |
18 |
18 |
18 |
18 |
82 |
82 |
82 |
82 |
82 |
95 |
95 |
94 |
116 |
Waluta |
USD |
USD |
USD |
USD |
USD |
USD |
USD |
USD |
USD |
USD |
USD |
USD |
USD |
USD |
USD |
USD |
USD |
USD |
USD |
USD |
USD |